Document is current
Any future updates will be listed below
-
Authors
Sadri, Bahareh
Hassanzadeh, Mohammad
Bagherifard, Abolfazl
Mohammadi, Javad
Alikhani, Mehdi
Moeinabadi-Bidgoli, Kasra
Madani, Hoda
Diaz-Solano, Dylana
Karimi, Shahedeh
Mehrazmay, Mohammad
Mohammadpour, Mehdi
Vosough, Massoud http://orcid.org/0000-0001-5924-4366
-
Funding
Funding for this research was provided by:
Iran Ministry of Health and Medical Education
Royan Institute
- License Information
-
More Information
Article History
Received: 19 November 2022
Accepted: 28 April 2023
First Online: 14 June 2023
Declarations
:
: The study “Evaluation of safety and efficacy of intra-articular transplantation of allogeneic adipose derived mesenchymal stromal cells in patients with knee joint osteoarthritis an interventional randomized triple-blind placebo controlled clinical trial phase I/II” was approved by the ethics committee of Royan institute on October 10, 2017, with the reference number of IR.ACECR.ROYAN.REC.1396.138. The study included only adults, and written informed consent has been obtained from the patients. All procedures were conducted in accordance with the relevant approved regulations, guidelines, and the Declaration of Helsinki.
: Not applicable.
: MV is the regulatory affairs manager at the cell production facility. He has no share in the company nor any financial benefit in this study. The other authors declare that they have no competing interests.
